| Year |
Citation |
Score |
| 2023 |
Collij LE, Farrar G, Zwan M, van de Giessen E, Ossenkoppele R, Barkhof F, Rozemuller AJM, Pijnenburg YAL, van der Flier WM, Bouwman F. Clinical outcomes up to 9 years after [F]flutemetamol amyloid-PET in a symptomatic memory clinic population. Alzheimer's Research & Therapy. 15: 207. PMID 38012799 DOI: 10.1186/s13195-023-01351-1 |
0.311 |
|
| 2022 |
Ingala S, van Maurik IS, Altomare D, Wurm R, Dicks E, van Schijndel RA, Zwan M, Bouwman F, Schoonenboom N, Boelaarts L, Roks G, van Marum R, van Harten B, van Uden I, Claus J, et al. Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease. European Radiology. PMID 35639148 DOI: 10.1007/s00330-021-08503-7 |
0.306 |
|
| 2022 |
van der Doelen DM, Handels RLH, Zwan MD, van Kuijk SMJ, Pelkmans W, Bouwman FH, Scheltens P, Dirksen CD, Verhey FRJ. The Impact of Amyloid PET Disclosure on Quality of Life in Patients With Young Onset Dementia. Alzheimer Disease and Associated Disorders. 36: 1-6. PMID 35200198 DOI: 10.1097/WAD.0000000000000470 |
0.322 |
|
| 2021 |
Collij LE, Salvadó G, Shekari M, Alves IL, Reimand J, Wink AM, Zwan M, Niñerola-Baizán A, Perissinotti A, Scheltens P, Ikonomovic MD, Smith APL, Farrar G, Molinuevo JL, Barkhof F, et al. Visual assessment of [F]flutemetamol PET images can detect early amyloid pathology and grade its extent. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33615397 DOI: 10.1007/s00259-020-05174-2 |
0.305 |
|
| 2019 |
Reimand J, de Wilde A, Teunissen CE, Zwan M, Windhorst AD, Boellaard R, Barkhof F, van der Flier WM, Scheltens P, van Berckel BNM, Ossenkoppele R, Bouwman F. PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases. Alzheimer's Research & Therapy. 11: 100. PMID 31810489 DOI: 10.1186/S13195-019-0561-5 |
0.311 |
|
| 2019 |
de Wilde A, Ossenkoppele R, Pelkmans W, Bouwman F, Groot C, van Maurik I, Zwan M, Yaqub M, Barkhof F, Lammertsma AA, Biessels GJ, Scheltens P, van Berckel BN, van der Flier WM. Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort: The ABIDE project. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31594684 DOI: 10.1016/J.Jalz.2019.07.003 |
0.321 |
|
| 2019 |
de Wilde A, Reimand J, Teunissen CE, Zwan M, Windhorst AD, Boellaard R, van der Flier WM, Scheltens P, van Berckel BNM, Bouwman F, Ossenkoppele R. Discordant amyloid-β PET and CSF biomarkers and its clinical consequences. Alzheimer's Research & Therapy. 11: 78. PMID 31511058 DOI: 10.1186/S13195-019-0532-X |
0.301 |
|
| 2019 |
Rodríguez-Gómez O, Rodrigo A, Iradier F, Santos-Santos MA, Hundemer H, Ciudin A, Sannemann L, Zwan M, Glaysher B, Wimo A, Bonn J, Johansson G, Rodriguez I, Alegret M, Gove D, et al. The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the community. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31076376 DOI: 10.1016/J.Jalz.2019.02.003 |
0.326 |
|
| 2019 |
Handels R, Zwan MD, Pelkmans W, Bouwman FH, Biessels GJ, Roks G, Schoonenboom NSM, Verwey NA, Berckel BNMV, Flier WMvd, Verhey FRJ, Scheltens P. Added Diagnostic Value Of 18F-Flutemetamol Pet Scanning In Young Patients With Dementia Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2772 |
0.329 |
|
| 2018 |
Willemse EAJ, van Maurik IS, Tijms BM, Bouwman FH, Franke A, Hubeek I, Boelaarts L, Claus JJ, Korf ESC, van Marum RJ, Roks G, Schoonenboom N, Verwey N, Zwan MD, Wahl S, et al. Diagnostic performance of Elecsys immunoassays for cerebrospinal fluid Alzheimer's disease biomarkers in a nonacademic, multicenter memory clinic cohort: The ABIDE project. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 563-572. PMID 30406175 DOI: 10.1016/j.dadm.2018.08.006 |
0.315 |
|
| 2018 |
Collij L, Konijnenberg E, Reimand J, Ten Kate M, Den Braber A, Lopes Alves I, Zwan M, Yaqub M, Van Assema D, Wink AM, Lammertsma A, Scheltens P, Visser PJ, Barkhof F, Van Berckel B. Assessing Amyloid Pathology in Cognitively Normal Subjects using [F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30315145 DOI: 10.2967/Jnumed.118.211532 |
0.337 |
|
| 2018 |
de Wilde A, van der Flier WM, Pelkmans W, Bouwman F, Verwer J, Groot C, van Buchem MM, Zwan M, Ossenkoppele R, Yaqub M, Kunneman M, Smets EMA, Barkhof F, Lammertsma AA, Stephens A, et al. Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project. Jama Neurology. PMID 29889941 DOI: 10.1001/Jamaneurol.2018.1346 |
0.395 |
|
| 2017 |
van Maurik IS, Zwan MD, Tijms BM, Bouwman FH, Teunissen CE, Scheltens P, Wattjes MP, Barkhof F, Berkhof J, van der Flier WM. Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project. Jama Neurology. PMID 29049480 DOI: 10.1001/Jamaneurol.2017.2712 |
0.304 |
|
| 2017 |
de Wilde A, van Maurik IS, Kunneman M, Bouwman F, Zwan M, Willemse EA, Biessels GJ, Minkman M, Pel R, Schoonenboom NS, Smets EM, Wattjes MP, Barkhof F, Stephens A, van Lier EJ, et al. Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design. Alzheimer's & Dementia (Amsterdam, Netherlands). 6: 143-151. PMID 28239639 DOI: 10.1016/J.Dadm.2017.01.003 |
0.4 |
|
| 2017 |
Zwan MD, Bouwman FH, Konijnenberg E, van der Flier WM, Lammertsma AA, Verhey FR, Aalten P, van Berckel BN, Scheltens P. Diagnostic impact of [(18)F]flutemetamol PET in early-onset dementia. Alzheimer's Research & Therapy. 9: 2. PMID 28093088 DOI: 10.1186/S13195-016-0228-4 |
0.321 |
|
| 2016 |
de Wilde A, van der Flier WM, Bouwman FH, Ossenkoppele R, Pelkmans W, Groot C, Zwan MD, Yaqub MM, Newman V, Lammertsma AA, van Berckel BN, Scheltens P. P1-297: The Diagnostic Value of Amyloid Pet in an Unselected Cohort of Memory Clinic Patients Alzheimer's & Dementia. 12: P534-P535. DOI: 10.1016/j.jalz.2016.06.1047 |
0.308 |
|
| 2016 |
Wilde Ad, Flier WMvd, Bouwman FH, Ossenkoppele R, Pelkmans W, Groot C, Zwan MD, Yaqub MM, Newman V, Lammertsma AA, Berckel BNMv, Scheltens P. The Diagnostic Value Of Amyloid Pet In An Unselected Cohort Of Memory Clinic Patients Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.021 |
0.318 |
|
| 2015 |
Zwan MD, Villemagne VL, Doré V, Buckley R, Bourgeat P, Veljanoski R, Salvado O, Williams R, Margison L, Rembach A, Macaulay SL, Martins R, Ames D, van der Flier WM, Ellis KA, et al. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden. Journal of Alzheimer's Disease : Jad. PMID 26639956 DOI: 10.3233/Jad-150446 |
0.312 |
|
| 2015 |
Zwan MD, Rinne JO, Hasselbalch SG, Nordberg A, Lleó A, Herukka SK, Soininen H, Law I, Bahl JM, Carter SF, Fortea J, Blesa R, Teunissen CE, Bouwman FH, van Berckel BN, et al. Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study. Neurology. PMID 26468410 DOI: 10.1212/Wnl.0000000000002081 |
0.348 |
|
| 2015 |
Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ, Verfaillie SC, Zwan MD, Adriaanse SM, Lammertsma AA, Barkhof F, Jagust WJ, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. Jama. 313: 1939-49. PMID 25988463 DOI: 10.1001/Jama.2015.4669 |
0.388 |
|
| 2014 |
Zwan MD, Okamura N, Fodero-Tavoletti MT, Furumoto S, Masters CL, Rowe CC, Villemagne VL. Voyage au bout de la nuit: Aβ and tau imaging in dementias. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology. 58: 398-412. PMID 25358680 |
0.357 |
|
| 2014 |
Zwan MD, Ossenkoppele R, Tolboom N, Beunders AJ, Kloet RW, Adriaanse SM, Boellaard R, Windhorst AD, Raijmakers P, Adams H, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN. Comparison of simplified parametric methods for visual interpretation of 11C-Pittsburgh compound-B PET images. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1305-7. PMID 24898026 DOI: 10.2967/Jnumed.114.139121 |
0.307 |
|
| 2014 |
Ossenkoppele R, van der Flier WM, Verfaillie SC, Vrenken H, Versteeg A, van Schijndel RA, Sikkes SA, Twisk J, Adriaanse SM, Zwan MD, Boellaard R, Windhorst AD, Barkhof F, Scheltens P, Lammertsma AA, et al. Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions. Neurology. 82: 1768-75. PMID 24748672 DOI: 10.1212/Wnl.0000000000000432 |
0.357 |
|
| 2014 |
Zwan M, van Harten A, Ossenkoppele R, Bouwman F, Teunissen C, Adriaanse S, Lammertsma A, Scheltens P, van Berckel B, van der Flier W. Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort. Journal of Alzheimer's Disease : Jad. 41: 801-7. PMID 24705549 DOI: 10.3233/Jad-132561 |
0.448 |
|
| 2014 |
Adriaanse SM, van Dijk KR, Ossenkoppele R, Reuter M, Tolboom N, Zwan MD, Yaqub M, Boellaard R, Windhorst AD, van der Flier WM, Scheltens P, Lammertsma AA, Barkhof F, van Berckel BN. The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 41: 1190-8. PMID 24615466 DOI: 10.1007/S00259-014-2704-Z |
0.309 |
|
| 2013 |
Ossenkoppele R, van der Flier WM, Zwan MD, Adriaanse SF, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van Berckel BN. Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia. Neurology. 80: 359-65. PMID 23255822 DOI: 10.1212/Wnl.0B013E31827F0889 |
0.358 |
|
| 2013 |
Zwan M, Harten Av, Ossenkoppele R, Bouwman F, Teunissen C, Adriaanse S, Lammertsma A, Scheltens P, Berckel BNMv, Flier WVd. Concordance between CSF biomarkers and [11C]PiB-PET in a memory clinic population Alzheimers & Dementia. 9: 13. DOI: 10.1016/J.Jalz.2013.05.008 |
0.348 |
|
| 2012 |
Ossenkoppele R, Zwan MD, Tolboom N, van Assema DM, Adriaanse SF, Kloet RW, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement. Brain : a Journal of Neurology. 135: 2115-25. PMID 22556189 DOI: 10.1093/Brain/Aws113 |
0.306 |
|
| 2012 |
Flier WVd, Ossenkoppele R, Adriaanse S, Zwan M, Boellaard R, Windhorst A, Barkhof F, Scheltens P, Lammertsma A, Berckel Bv. Differential impact of apolipoprotein E genotype on distributions of amyloid load and glucose metabolism in Alzheimer's disease Alzheimers & Dementia. 8: 618. DOI: 10.1016/J.Jalz.2012.05.1646 |
0.309 |
|
| 2012 |
Ossenkoppele R, Zwan M, Tolboom N, Assema DME, Adriaanse S, Barkhof F, Lammertsma A, Scheltens P, Flier WVd, Berckel Bv. Increased parietal amyloid burden and metabolic dysfunction in Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.119 |
0.358 |
|
| Show low-probability matches. |